ELK1 and Alzheimer disease: Previous findings have reported that no obvious alteration of total ELK1 expression was occurred in vitro following Aβ1‐42 treatment, alongside nuclear Elk‐1 phosphorylation level remained unchanged in hippocampal slices of AD mice (Liu et al., 2019; Szatmari et al., 2013).